A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...

A new drug could put an end to cumbersome CPAP machines, which are thought to be used by some 33 million Americans to manage their sleep apnea. Roughly 39 million Americans, including President Biden, ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...

Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. The Massachusetts biotech reported May 19 that AD109 met the primary endpoint of a phase 3 trial, reducing ...

Zepbound, a drug that rivals Ozempic, may one day be a treatment for sleep apnea, according to results from a new study. Jessica was a writer on the Wellness team, with a focus on health technology, ...

Weight loss pills and injections are often touted as miracle drugs. Research shows that they can help you lose weight, better help you manage type II diabetes, and even reduce your risk of heart ...

(CNN) — Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said Wednesday. Based on results from trials in people with sleep apnea, the ...